Condensed Consolidated Statements of Operations - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Revenues | ||||
| Revenues | $ 1,774,651 | $ 1,726,541 | $ 3,272,355 | $ 3,545,355 |
| Expenses | ||||
| Salaries and wages | 674,363 | 743,000 | 1,307,715 | 1,432,482 |
| Professional fees | 174,488 | 142,710 | 360,878 | 377,840 |
| Insurance | 79,908 | 89,685 | 163,022 | 172,293 |
| Outsource service fees | 230,144 | 179,590 | 445,219 | 353,140 |
| Data maintenance | 59,076 | 62,067 | 85,370 | 198,182 |
| General and administrative | 187,276 | 205,930 | 368,069 | 393,440 |
| Total expenses | 1,405,255 | 1,422,982 | 2,730,273 | 2,927,377 |
| Income from operations | 369,396 | 303,559 | 542,082 | 617,978 |
| Other income (expense) | ||||
| Other income | 0 | 419,801 | 0 | 419,801 |
| Interest income | 94,229 | 172,315 | 189,414 | 266,059 |
| Interest expense | 0 | 0 | 0 | (1,522) |
| Total other income, net | 94,229 | 592,116 | 189,414 | 684,338 |
| Income before taxes | 463,625 | 895,675 | 731,496 | 1,302,316 |
| Income tax provision | 136,617 | 258,768 | 210,819 | 372,746 |
| Net income | $ 327,008 | $ 636,907 | $ 520,677 | $ 929,570 |
| Basic earnings per share: | ||||
| Net Income per share amount (in Dollars per share) | $ 0.03 | $ 0.05 | $ 0.04 | $ 0.07 |
| Weighted average shares outstanding, basic (in Shares) | 12,800,000 | 12,800,000 | 12,800,000 | 12,800,000 |
| Fully diluted earnings per share: | ||||
| Net Income per share amount (in Dollars per share) | $ 0.03 | $ 0.05 | $ 0.04 | $ 0.07 |
| Weighted average shares outstanding, diluted (in Shares) | 12,816,000 | 12,816,000 | 12,816,000 | 12,816,000 |
| HCO | ||||
| Revenues | ||||
| Revenues | $ 302,737 | $ 320,387 | $ 488,963 | $ 814,516 |
| MPN | ||||
| Revenues | ||||
| Revenues | 146,040 | 170,215 | 300,974 | 329,220 |
| Medical Bill Review | ||||
| Revenues | ||||
| Revenues | 140,233 | 84,332 | 259,268 | 212,909 |
| Utilization Review | ||||
| Revenues | ||||
| Revenues | 616,105 | 531,335 | 1,153,702 | 1,026,377 |
| Medical Case Management | ||||
| Revenues | ||||
| Revenues | 563,336 | 617,572 | 1,063,198 | 1,133,883 |
| Other | ||||
| Revenues | ||||
| Revenues | $ 6,200 | $ 2,700 | $ 6,250 | $ 28,450 |
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|